Journal
YONSEI MEDICAL JOURNAL
Volume 53, Issue 5, Pages 886-893Publisher
YONSEI UNIV COLL MEDICINE
DOI: 10.3349/ymj.2012.53.5.886
Keywords
Glycosylation; hemagglutinin; influenza virus; pandemic
Categories
Funding
- Ministry of Health & Welfare, Republic of Korea [A103001]
- Hallym University Research Fund [HRF-2007-043]
Ask authors/readers for more resources
Since the 1918 influenza A virus (IAV) pandemic, H1N1 viruses have circulated in human populations. The hemagglutinin (HA) of IAV determines viral antigenicity and often undergoes N-linked glycosylation (NLG) at several sites. Interestingly, structural analysis of the 1918 and 2009 H1N1 pandemic viruses revealed antigenic similarities attributable to the conserved epitopes and the NLG statuses of their HA proteins. NLG of the globular head of HA is known to modulate the antigenicity, fusion activity, virulence, receptor-binding specificity, and immune evasion of IAV. In addition, the HA of IAV often retains additional mutations. These supplemental mutations compensate for the attenuation of viral properties resulting from the introduced NLG. In human H1N1 viruses, the number and location of NLG sites has been regulated in accordance with the antigenic variability of the NLG-targeted antibody-binding site. The relationship between the NLG and the antigenic variance in HA appears to be stably controlled in the viral context.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available